This press release shows us the difficulty to bring a “hair loss cure” to market. Much hope had gone into the possibilities that this new treatment for hair loss could bring, but ultimately, it did not meet safety requirements for Procter & Gamble, who collaborated on this product with Curis.
From the press release:
Procter & Gamble has notified Curis that it has decided to terminate the collaboration agreement with Curis because the Hedgehog agonist compounds under development pursuant to the collaboration did not demonstrate an acceptable safety profile. Pursuant to the collaboration agreement, the agreement will terminate in six months.